Use of pro-atrial natriuretic peptide in the detection of myocardial ischaemia

European Journal of Clinical Investigation

Volumn 35, Issue 7, 2005, Pages 450-456

  Bocek, T ^a   Morgenthaler, N G ^b   Staub, D ^a   Nusbaumer, C ^a   Christ, A ^a   Zellweger, M J ^a   Mueller Brand, J ^a   Mueller, B ^a   Perruchoud, A P ^a   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BRAHMS AG   (Germany)

Author keywords

Exercise; Ischaemia; Natriuretic peptides

Indexed keywords

NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ERGOMETRY; EXERCISE; FEMALE; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MALE; PRIORITY JOURNAL; ROC CURVE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; ROC CURVE; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 22244478624     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01517.x     Document Type: Article

References (37)

1. Greenland P, Gaziano JM. Clinical practice. Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. N Engl J Med 2003;349:465-73.
2. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froehlicher VF et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at www.acc.org/clinical/guidelines/ exercise/dirIndex.htm. Last accessed December 12, 2004.
3. Grech ED. Pathophysiology and investigation of coronary artery disease. BMJ 2003;326:1027-30.
4. Davis M, Espiner E, Richards G, Billings J, Town I, Neill A et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet 1994;343:440-4.
5. Wei CM, Kao PC, Lin JT, Heublein DM, Schaff HV, Burnett JC Jr. Circulating beta-atrial natriuretic factor in congestive heart failure in humans. Circulation 1993;88:1004-49.
6. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
7. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
8. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Due P et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
9. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647-54.
10. Marie PY, Mertes PM, Hassan-Sebbag N, de Talence N, Djaballah K, Djaballah W et al. Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers. J Am Coll Cardiol 2004;43:353-9.
11. Asada J, Tsuji H, Iwasaka T, Thomas JD, Lauer MS. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia. Am J Cardiol 2004;93:702-4.
12. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 2003;108:2987-92.
13. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci 1995;88:551-6.
14. Nicholson S, Richards M, Espiner E, Nicholls G, Yandle T. Atrial and brain natriuretic peptide response to exercise in patients with ischemic heart disease. Clin Exp Pharmacol Physiol 1993;20:535-40.
15. Foote RS, Pearlman JD, Siegel AH, Yeo KT. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 2004;44:1980-7.
16. Nishikimi T, Mori Y, Ishimura K, Tadokoro K, Yagi H, Yabe A et al. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function. Am J Med 2004;116:517-23.
17. Sabatine MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tanasijevic M et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004;44:1988-95.
18. Vesely DL. Atrial natriuretic peptide prohormone gene expression: hormones and diseases that upregulate its expression. IUBMB Life 2002;53:153-9.
19. Cappellin E, Gatti R, Spinella P, De Palo CB, Woloszczuk W, Maragno I et al. Plasma atrial natriuretic peptide (ANP) fragments proANP (1-30) and proANP (31-67) measurements in chronic heart failure: a useful index for heart transplantation? Clin Chim Acta 2001;310:49-52.
20. Daggubati S, Parks JR, Overton RM, Cintron G, Schocken DD, Vesely DL. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators. Cardiovasc Res 1997;36:246-55.
21. Morgenthaler NG, Struck J, Thomas B, Bergmann A. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 2004;50:234-6.
22. Gill JS, Prasad K, Stewart JT, Pumphrey CW, Holt DW, McKenna WJ et al. Acute changes in atrial natriuretic peptide, insulin-like growth factor-1, and lactate levels during left anterior descending coronary artery angioplasty. Am Heart J 1995;130:717-22.
23. Malatino LS, Leonardi C, Stancanelli B, Polizzi G, Grassi R, Tamburino C et al. Transient myocardial ischemia stimulates atrial natriuretic factor release. Am Heart J 1992;123:693-8.
24. Prachar H, Ogris E, Dittel M, Enenkel W. Rapid changes of atrial natriuretic peptide concentration during percutaneous transluminal coronary angioplasty. Am Heart J 1991;122:157-63.
25. Herman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455-64.
26. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
27. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.
28. Ala-Kopsala M, Magga J, Peuhkurinen K, Leipala J, Ruskoaho H, Leppaluoto J et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 2004;50:1576-88.
29. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
30. Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-9.
31. Wang TJ, Larson MG, Lewy D, Benjamin EJ, Leip EP, Omland T et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-63.
32. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-75.
33. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
34. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004;43:635-41.
35. Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Muller B. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 2005;9:R37-45.
36. White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 1984;310:819-24.
37. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek J et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-8.